It has been said that we are on the brink of some major breakthroughs in cancer treatments… and recent headlines reflect just that.
In this podcast: Sanford Roger Maris Cancer Center Oncologist, Dr. Shelby Terstriep explains the most recent news. And why she believes this is just the beginning…
The medication, called Vitrakvi, is the second treatment to receive FDA clearance based on a common biomarker found in an array of cancers. The drug, also called larotrectinib, was approved simultaneously for adults and children. Typically, oncology drugs are considered much later for children.
Last year the agency, for the first time, approved an immunotherapy drug for tumors with a specific genetic signature, regardless of where they originated in the body. But that treatment had been cleared for several cancers, including advanced melanoma. (
Click here
to read more.)
Related content you might like:
GOOD NEWS: A New Anti-Flu Pill Has Been Approved!
The IMA Doctors Show – Recreational vs. Medical Genomics
(Amy Iler & JJ Gordon are talk-show hosts at 790 AM KFGO in Fargo-Moorhead. “It Takes 2 with Amy & JJ” can be heard weekdays 11am-2pm. Check out the show page on
FACEBOOK.
Follow Amy on Twitter
@AmyKFGO
. Follow JJ on Twitter
@JJGodon701
.)
